PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
This Quarter Return
-6.65%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$3.28B
AUM Growth
+$3.28B
(-20%)
Cap. Flow
-$697M
Cap. Flow
% of AUM
-21.29%
Top 10 Holdings %
Top 10 Hldgs %
43.2%
Holding
108
New
22
Increased
17
Reduced
27
Closed
31
Top Buys
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$142M |
| 2 |
NXP Semiconductors
NXPI
|
$77.5M |
| 3 |
Cigna
CI
|
$60.4M |
| 4 |
Novartis
NVS
|
$59.7M |
| 5 |
PTC Therapeutics
PTCT
|
$55.9M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
$224M |
| 2 |
Humana
HUM
|
$149M |
| 3 |
ICU Medical
ICUI
|
$97.4M |
| 4 |
Sarepta Therapeutics
SRPT
|
$83.1M |
| 5 |
Alibaba
BABA
|
$82M |
Sector Composition
| 1 | Healthcare | 61.59% |
| 2 | Technology | 15.83% |
| 3 | Financials | 1.15% |
| 4 | Communication Services | 1.06% |
| 5 | Consumer Discretionary | 0.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
BioMarin Pharmaceuticals
BMRN
$11.2B
| $145M | 4.28% | 2,149,051 +69,663 | +3% | +$4.7M |
|
|
ALXN
2
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $142M | 4.18% | +1,446,612 | New | +$142M |
|
3
Penumbra
PEN
$10.6B
| $138M | 4.09% | 1,029,564 +257,765 | +33% | +$34.7M |
|
4
Zimmer Biomet
ZBH
$21B
| $136M | 4% | 987,842 -177,652 | -15% | -$24.4M |
|
5
Gilead Sciences
GILD
$140B
| $117M | 3.45% | 1,843,860 +479,572 | +35% | +$30.4M |
|
|
ARNA
6
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $104M | 3.07% | 2,271,536 +443,158 | +24% | +$20.3M |
|
7
iRhythm Technologies
IRTC
$5.46B
| $80.1M | 2.37% | 1,081,059 +398,096 | +58% | +$29.5M |
|
|
8
NXP Semiconductors
NXPI
$59.2B
| $77.5M | 2.29% | +709,930 | New | +$77.5M |
|
9
Microchip Technology
MCHP
$35.1B
| $77.2M | 2.28% | 830,494 +76,965 | +10% | +$7.15M |
|
|
AGN
10
DELISTED
Allergan plc
AGN
| $76.7M | 2.26% | 455,598 -1,329,999 | -74% | -$224M |
|
11
IQVIA
IQV
$32.4B
| $71.3M | 2.1% | 477,002 -161,324 | -25% | -$24.1M |
|
|
WCG
12
DELISTED
Wellcare Health Plans, Inc.
WCG
| $68.3M | 2.02% | 263,626 -216,618 | -45% | -$56.1M |
|
|
BOLD
13
DELISTED
Audentes Therapeutics, Inc
BOLD
| $65.1M | 1.92% | 2,315,938 -912,741 | -28% | -$25.6M |
|
|
MYOK
14
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $64M | 1.89% | 1,227,371 -550,038 | -31% | -$28.7M |
|
15
DexCom
DXCM
$29.5B
| $63.9M | 1.89% | 428,242 +16,546 | +4% | +$2.47M |
|
|
16
Cigna
CI
$80.3B
| $60.4M | 1.78% | +397,684 | New | +$60.4M |
|
|
17
Novartis
NVS
$245B
| $59.7M | 1.76% | +689,600 | New | +$59.7M |
|
18
Twilio
TWLO
$16.2B
| $58.8M | 1.74% | 534,889 +218,747 | +69% | +$24.1M |
|
|
19
PTC Therapeutics
PTCT
$3.92B
| $55.9M | 1.65% | +1,654,225 | New | +$55.9M |
|
20
Edwards Lifesciences
EW
$47.8B
| $55.4M | 1.63% | 251,754 -204,605 | -45% | -$45M |
|
21
Molina Healthcare
MOH
$9.8B
| $54M | 1.59% | 491,797 -49,101 | -9% | -$5.39M |
|
|
CTLT
22
DELISTED
CATALENT, INC.
CTLT
| $52.7M | 1.56% | 1,106,773 +489,754 | +79% | +$23.3M |
|
|
SAGE
23
DELISTED
Sage Therapeutics
SAGE
| $52.4M | 1.55% | +373,828 | New | +$52.4M |
|
24
Salesforce
CRM
$245B
| $52M | 1.54% | 350,422 -248,337 | -41% | -$36.9M |
|
25
HCA Healthcare
HCA
$94.5B
| $50.2M | 1.48% | 416,733 -213,034 | -34% | -$25.7M |
|